Company intelligence / Profile preview

Beijing Deli Furui Medical Science & Technology

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Beijing Deli Furui Medical Science & Technology is a clinical-stage biopharmaceutical company based in Beijing, China, dedicated to the discovery and development of novel small molecule therapeutics. The company primarily focuses on oncology, targeting advanced solid tumors with high unmet medical needs. Its lead candidate, DLFR-101, is currently undergoing Phase 1 clinical trials to evaluate its safety, tolerability, and preliminary efficacy in patients with advanced malignancies. Deli Furui utilizes its internal research capabilities to build a pipeline of targeted therapies aimed at providing more effective treatment options for cancer patients.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Beijing Deli Furui Medical Science & Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Deli Furui Medical Science & Technology.

Explore the full profile